ArticleNPJ precision oncology2026

Multimodal plasma and urinary cell-free DNA profiling improves risk stratification in newly diagnosed prostate cancer.

Anja Lisa Riediger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.